Phase II study of Dong-A's new impotence drug successful.

Published: 2004-04-30 06:59:00
Updated: 2004-04-30 06:59:00
Dong-A (President: Kang Moon-seok) announced that the phase II clinical study for DA8159, an oral impotence drug, had been successfully completed against the total 319 patients in 9 month trial.

According to the phase II clinical studies performed for impotence patients at 13 general hospitals...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.